Squadron Capital Management LLC
CIK: 0002050709SEC EDGAR →
Portfolio Value
$236.0M
Holdings
33
As of
Q4 2025
New Positions
33
Closed Positions
0
Top 10 Holdings
| Rank | Stock | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | RELMADA THERAPEUTICS INC | 6,700,000 | $32.4M | 13.71% |
| 2 | COGENT BIOSCIENCES INC | 780,000 | $27.7M | 11.74% |
| 3 | MAZE THERAPEUTICS INC | 490,000 | $20.3M | 8.60% |
| 4 | ABIVAX SA | 145,000 | $19.6M | 8.29% |
| 5 | KALVISTA PHARMACEUTICALS INC | 700,000 | $11.3M | 4.79% |
| 6 | PALISADE BIO INC | 4,500,000 | $10.6M | 4.48% |
| 7 | EDGEWISE THERAPEUTICS INC | 350,000 | $8.7M | 3.68% |
| 8 | INHIBIKASE THERAPEUTICS INC | 4,225,000 | $8.7M | 3.67% |
| 9 | KODIAK SCIENCES INC | 291,710 | $8.2M | 3.46% |
| 10 | TERNS PHARMACEUTICALS INC | 190,000 | $7.7M | 3.25% |
Sector Breakdown
| Sector | # Holdings | Value | % |
|---|---|---|---|
| Healthcare | 33 | $236.0M | 100.0% |